Yi Lu

2PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 11, 2021
MONARCH 2: Subgroup Analysis of Patients Receiving Abemaciclib Plus Fulvestrant as First-Line and Second-Line Therapy for HR<sup>+</sup>, HER2<sup>-</sup>-Advanced Breast Cancer.

Patrick Neven, Stephen R D Johnston, Masakazu Toi

|Nov 05, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III study.

Qing Yuan Zhang, Tao Sun, Yong Mei Yin

Pageof 1

Frequent Collaborators

1 joint publications

Masakazu Toi

1 joint publications

Norikazu Masuda

1 joint publications

PierFranco Conte

1 joint publications

Antonio Llombart-Cussac